DOI QR코드

DOI QR Code

강원도 저소득층의 전립선질환 검진사업과 사후관리를 위한 유관기관 협력방안

Directions for Muti-institutional Cooperation in Follow-up Management of Prostatic Disease Screening for the Low-income Group in Gangwon-do

  • 장성옥 (한국건강관리협회 강원도지부, 한림대학교 경영학부) ;
  • 이종석 (한림대학교 경영학부)
  • Jang, Sungok (Korea Association of Health Promotion Gang-Won Branch) ;
  • Lee, Jongseok (School of Business Administration, Hallym University)
  • 투고 : 2013.08.15
  • 심사 : 2013.09.26
  • 발행 : 2013.10.01

초록

Objectives: This study aimed to investigate factors related to prostate disease and follow-up procedure on health examination program in Gangwon-do. Methods: The studied population was 16,501 male aged 40 or more, who underwent screening tests for prostatic disease in 2011 health examination program designed for the low income residents in Gangwon-do. The screening tests included prostate specific antigen (PSA), international symptom score (IPSS), and maximal flow rate (Qmax). We conducted chi-square test for trend, two independent samples t-test, and binary logistic regression to find out the relationship between prostate cancer or benign prostatic hyperplasia and risk factors such as age, PSA level, and IPSS. Results: The number of subjects who turned out positive for PSA level (> 3.8ng/ml) was 971 men accounting for 5.9%. The result of post survey on them showed that 511 subjects (52.6%) got the urology check-up: 156 (30.5%) were diagnosed as normal, 286 (56.0%) as benign prostatic hyperplasia, and 69 (13.5%) as prostate cancer. The detection rate for prostate cancer was 8.8% when PSA level was between 3.81 and 9.99g/ml, and was 30.6% when PSA level was more than 10.00ng/ml. The rates of further testing varied depending on the communities from 26.7% to 68.2%, which was mainly affected by the role of local health center. Conclusions: Our findings indicate that enhanced quality control of local health center and empowerment of screening agency would increase the effort of coupled institutions between public and private sectors.

키워드

참고문헌

  1. Barry, M. J., Fowler, F. J., O'leary, M. P., Brukewitz, R. C., Holdrewe, H. L., & Mebust, W. K. (1992). The American urological association symptom index for benign prostatic hyperplasia. Journal of Urology, 148, 1549-1557.
  2. Carter, H. B., Pearson, J. D., Metter, E. J., Chan, D. W., Andres, R., Fozard, J. L., & Walsh, P. C. (1992). Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. Journal of American Medical Association, 267, 2215-2220. https://doi.org/10.1001/jama.1992.03480160073037
  3. Catalona, W. J., Ramos, C. G., Carvalhal, C. F., & Yan, Y. (2000). Lowering PSA cutoffs to enhance of curable prostate cancer. Urology, 55, 791-795. https://doi.org/10.1016/S0090-4295(99)00602-0
  4. Catalona, W. J., Hudson, M. A., Sardino, P. T., Richie, J. P., Ahmann, F. R., Flanigan, R. C., . . . Dalkin, B. L. (1994). Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: Receiver operating charctersistic curves. Journal of Urology, 152, 2037-2042.
  5. Catalona, W. J., Smith, D. S., Ratliff, T. L., Todds, K. M., Coplen, D. E., & Yuan, J. J. (1991). Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New England Journal of Medicine, 325, 963-965. https://doi.org/10.1056/NEJM199109263251313
  6. Cho, H. I. (2012). Challenges and future directions for health promotion practice and research in private sectors: Focusing on the KAHP experience. Korean Journal of Health Education and Promotion, 29(4), 40-56.
  7. Choi, E. J., Kim, D. J., Lee, W. C., & Hwang, I. Y. (2009). Establishment of an efficient management system for advanced outcome of the national health screening policy. Seoul, Korea: Korea Institute for Health Social Affairs
  8. Jang, S. C., Sohn, H. S., Min, K. S., Urm, S. H., Lee, J. T., & Chun, J. H. (2004). Significance of PSA test for screening prostate cancer in health examinee. Korean Journal of Health Promotion and Disease Prevention, 4(3), 178-184.
  9. Kim, J. M., Lee, C. Y., & Chung, M. K. (2009). Application of 'CHIBA program' to predict probability of positive prostate biopsy in Korean. Korean Journal of Urology, 7(1), 16-20.
  10. Ku, J. H. (2006). Race-specific reference ranges of serum prostate specific antigen levels in countries with a low incidence of prostate cancer. British Journal of Urology International, 97, 69-72. https://doi.org/10.1111/j.1464-410X.2005.05866.x
  11. Kwon, T. M., Jeong, I. G., Hong, J. H., Ahn, H. J., & Kim, C. S. (2009). Analysis of the clinicopathologic characteristics of men with prostate cancer undergoing radical prostatectomy in the prostate-specific antigen range of less than 4 ng/ml. Korean Journal of Urology, 50(4), 320-326. https://doi.org/10.4111/kju.2009.50.4.320
  12. Lee, A. K., Lee, S. Y., Yoon, T. H., & Jeong, B. G. (2009). The effect of follow-up management service on health promotion for obesity population classified in health screening of National Health Insurance Corporation. Korean Journal of Health Education and Promotion, 26(3), 75-83.
  13. Lee, J. Y. (2012). Future directions for health promotion programs in the public sector. Korean Journal of Health Education and Promotion, 29(4), 29-38.
  14. Lee, K. N., Yoon, J. H., Cho, H. I., Na, E. H., Moon, S. Y., Park, J. Y., & Kang, W. S. (2009). A Study on reference values from health checkup data of Korea Association of Health Promotion by indirect method. Journal Laboratory Medicine & Quality Assurance, 31, 309-315.
  15. Lee, K. N., Yoon, J. H., Choi, Y. H., Cho, H. I., Bae, K. W., Yoon, C. H., & Kim, S. I. (2002). Standardization of reference values among laboratories of Korean Association of Health Promotion. Journal Laboratory Medicine & Quality Assurance, 24, 185-195.
  16. Park, Y. M., Lee, W. C., Im, H. W., Jung, H. S., Sohn, H. Y., Yoon, K. H., . . . Cho, S. J. (2006) Development of community-based health promotion service model considering the linkage of screenign and follow-up of subjects with life style related disease. Seoul, Korea: Catholic University College of Medicine, Health Promotion Business Support Group.
  17. Pickett, G., & Hanlon, J. J. (1990). Public health: Administration and practice (9th ed.). St. Louis, MI: Times Mirror/Mosby College Publishing.
  18. Punglia, R. S., D'Amico, A. V., Catalona, W. J., Roehl, K. A., & Kuntz, K. M. (2003). Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. New England Journal of Medicine, 349(4), 335-42. https://doi.org/10.1056/NEJMoa021659
  19. Rosner, B. (2011). Fundamentals of biostatistics (7th Ed.). Oxford, England: Brooks/Cole.
  20. Scheltens, T., Bots, M. L., Numans, M. E., Grobbee, D. E., & Hoes, A. W. (2007). Awareness, treatment and control of hypertension: The 'rule of halves' in an era of risk-based treatment of hypertension. Journal of Human Hypertension, 21, 99-106. https://doi.org/10.1038/sj.jhh.1002123
  21. Smith, R. A., Cokkinides, V., & Eyre, H. J. (2007). Cancer screening in the United States, 2007: A review of current guidelines, practices, and prospects. CA-Cancer Journal for Clinicians, 57, 90-104. https://doi.org/10.3322/canjclin.57.2.90
  22. Yoo, S. H. (2012). Community participation for health promotion: Definitions and applications. Korean Journal of Health Education and Promotion, 29(4), 57-66.